IF
IRON Financial Portfolio holdings
AUM
$189M
This Quarter Return
+5.9%
1 Year Return
+14.86%
3 Year Return
+39.68%
5 Year Return
+58.8%
10 Year Return
+116.22%
AUM
$224M
AUM Growth
+$224M
(+7.5%)
Cap. Flow
+$4.81M
Cap. Flow
% of AUM
2.14%
Top 10 Holdings %
Top 10 Hldgs %
56.43%
Holding
116
New
6
Increased
77
Reduced
23
Closed
1
Top Buys
Top Sells
| 1 |
CME Group
CME
|
$1.3M |
| 2 |
Fidelity Total Bond ETF
FBND
|
$1.16M |
| 3 |
Tesla
TSLA
|
$462K |
| 4 |
Moderna
MRNA
|
$220K |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
$182K |
Sector Composition
| 1 | Financials | 9.69% |
| 2 | Technology | 8.17% |
| 3 | Consumer Discretionary | 2.72% |
| 4 | Healthcare | 2.64% |
| 5 | Communication Services | 1.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Exxon Mobil
XOM
$487B
| $230K | 0.1% |
3,763
+129
| +4% | +$7.89K |
|
102
Mercado Libre
MELI
$125B
| $225K | 0.1% |
167
+4
| +2% | +$5.39K |
|
103
iShares Select Dividend ETF
DVY
$20.8B
| $223K | 0.1% |
1,823
+7
| +0.4% | +$856 |
|
104
Western Union
WU
$2.8B
| $212K | 0.09% |
11,877
+442
| +4% | +$7.89K |
|
105
MongoDB
MDB
$25.7B
| $210K | 0.09% |
+396
| New | +$210K |
|
106
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$13.8B
| $210K | 0.09% |
2,070
| – | – |
|
107
iShares MSCI Emerging Markets ETF
EEM
$19B
| $207K | 0.09% |
4,228
-499
| -11% | -$24.4K |
|
108
Intuitive Surgical
ISRG
$170B
| $204K | 0.09% |
+567
| New | +$204K |
|
109
Devon Energy
DVN
$22.9B
| $202K | 0.09% |
+4,592
| New | +$202K |
|
110
Starbucks
SBUX
$100B
| $201K | 0.09% |
+1,720
| New | +$201K |
|
111
iShares Core Total USD Bond Market ETF
IUSB
$34B
| $200K | 0.09% |
3,780
+21
| +0.6% | +$1.11K |
|
112
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.29B
| $179K | 0.08% |
+11,480
| New | +$179K |
|
113
NOV
NOV
$4.94B
| $169K | 0.08% |
12,446
+420
| +3% | +$5.7K |
|
114
DNP Select Income Fund
DNP
$3.68B
| $142K | 0.06% |
13,027
+246
| +2% | +$2.68K |
|
115
Lumen
LUMN
$5.1B
| $129K | 0.06% |
+10,281
| New | +$129K |
|
|
116
Moderna
MRNA
$9.37B
| – | – |
-571
| Closed | -$220K |
|